Cross-Talks between RKIP and YY1 through a Multilevel Bioinformatics Pan-Cancer Analysis

@article{Baritaki2023CrossTalksBR,
  title={Cross-Talks between RKIP and YY1 through a Multilevel Bioinformatics Pan-Cancer Analysis},
  author={Stavroula Baritaki and Apostolos Zaravinos},
  journal={Cancers},
  year={2023},
  volume={15},
  url={https://api.semanticscholar.org/CorpusID:264063615}
}
The findings underscore the significant role of the interplay between YY1 and PEBP1 in cancer progression, influencing genomic changes, tumor immunity, or the tumor microenvironment, as well as opening new avenues for cancer therapy.
[PDF] Semantic Reader

Figures from this paper

7 Citations

A Multi-Omics Analysis of an Exhausted T Cells’ Molecular Signature in Pan-Cancer

The importance of reviving exhausted T cells to enhance the treatment efficacy to significantly boost anti-tumor immunity and achieve better clinical outcomes is highlighted.

Therapeutic Implications of Targeting YY1 in Glioblastoma

The successful targeting of YY1 emerges as a promising avenue for reshaping GBM treatment strategies, presenting opportunities for innovative therapeutic approaches and enhanced patient outcomes.

A multi-omics analysis of effector and resting treg cells in pan-cancer

The Role of Phosphatidylethanolamine-Binding Protein (PEBP) Family in Various Diseases: Mechanisms and Therapeutic Potential.

RKIP overexpression reduces lung adenocarcinoma aggressiveness and sensitizes cells to EGFR-targeted therapies.

Overall, the findings indicate that RKIP modulates LUAD progression and response to EGFR-targeted therapies, although its clinical value as a biomarker requires further validation.

Targeting the YY1-Bcl2-c-Myc Axis in the treatment of non-Hodgkin lymphoma.

Raf-kinase inhibitor protein (RKIP): A therapeutic target in colon cancer.

114 References

Computational Analyses of YY1 and Its Target RKIP Reveal Their Diagnostic and Prognostic Roles in Lung Cancer

The reported findings indicate that YY1 and RKIP expression levels may play a role in LC as potential biomarkers and therapeutic targets, however, further studies will be necessary to validate the in silico results.

A Systematic Pan-Cancer Analysis of YY1 Aberrations and their Relationship with Clinical Outcome, Tumor Microenvironment, and Therapeutic Targets

This first pan‐cancer analysis offers a pretty comprehensive knowledge of YY1’s oncogenic involvement in various cancers.

Understanding Mechanisms of RKIP Regulation to Improve the Development of New Diagnostic Tools

The main mechanisms that regulate the expression and activity of RKIP were discussed with the aim of identifying the link between the transcriptional, post-transcriptional and post- translational events in different tumour settings.

Functional Linkage of RKIP to the Epithelial to Mesenchymal Transition and Autophagy during the Development of Prostate Cancer

RKIP interacts with EMT and autophagy as part of the same functional unit in developing prostate cancer.

Targeting Transcription Factor YY1 for Cancer Treatment: Current Strategies and Future Directions

Y1 biology, its role in cancer, and various strategies for targeting YY1, including small molecule inhibitors, RNA interference, and gene editing techniques are explored, with a focus on their clinical implications.

Inverse correlation between the metastasis suppressor RKIP and the metastasis inducer YY1: Contrasting roles in the regulation of chemo/immuno-resistance in cancer.

A pan-cancer proteomic perspective on The Cancer Genome Atlas

R reverse-phase protein arrays are used to analyse 3,467 patient samples from 11 TCGA ‘Pan-Cancer’ diseases, providing a resource to study the prognostic and therapeutic potential of tumour proteins.

The biological implications of Yin Yang 1 in the hallmarks of cancer

Recent progress with respect to YY1 and its biological implications in the context of hallmarks of cancer is summarized.

Yin Yang 1 expression in human tumors

The Yin Yang 1 (YY1) transcription factor has been identified to target a plethora of potential target genes, the products of which are important for proliferation and differentiation. The mechanisms…

The Genomic Landscape and Pharmacogenomic Interactions of Clock Genes in Cancer Chronotherapy.

...